The importance of distinguishing between the odds ratio and the incidence rate ratio in GWAS

In recent years, genome wide association studies have identified many genetic variants that are consistently associated with common complex diseases, but the amount of heritability explained by these risk alleles is still low. Part of the missing heritability may be due to genetic heterogeneity and small sample sizes, but non-optimal study designs in many genome wide association studies may also have contributed to the failure of identifying gene variants causing a predisposition to disease. The normally used odds ratio from a classical case-control study measures the association between genotype and being diseased. In comparison, under incidence density sampling, the incidence rate ratio measures the association between genotype and becoming diseased. We estimate the differences between the odds ratio and the incidence rate ratio under the presence of events precluding the disease of interest. Such events may arise due to pleiotropy and are known as competing events. In addition, we investigate how these differences impact the association test.

We simulate life spans of individuals whose gene variants are subject to competing events. To estimate the association between genotype and disease, we applied classical case-control studies and incidence density sampling.

If the interest is on the aetiology of the disease, a design based on incidence density sampling provides the preferred interpretation of the estimate. Under a classical case-control design and in the presence of competing events, the change in p-values in the association test may lead to false positive findings and, more importantly, false negative findings. The ranking of the SNPs according to p-values may differ between the two study designs.